BIOXYTRAN, INC Contracts & Agreements

99 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Public Offering Subscription Agreement
Subscription Agreements
BIOXYTRAN, INC
Biotechnology
2019
Extract from Valuation Report of NDPD Pharma, dated October 1, 2024
BIOXYTRAN, INC
2024
Stock Sale and Purchase Agreement of NDPD Pharma, dated October 25, 2024
Stock Agreements
BIOXYTRAN, INC
2024
Joint Venture Agreement between Bioxytran, the Heme Foundation and NDPD Pharma, dated July 15, 2024
Joint Venture Agreements
BIOXYTRAN, INC
2024
Certificate of Designation of Convertible Preferred Stock, dated April 19, 2024
Stock Agreements
BIOXYTRAN, INC
2024
Option Agreement for conversion/exchange between Pharmalectin, Inc. and Bioxytran, Inc. shares of Common Stock, dated November 20, 2021
Stock Agreements
BIOXYTRAN, INC
2024
Securities Purchase Agreement between Bioxytran, Inc. and Lender, dated March 15, 2024
Purchase Agreements
BIOXYTRAN, INC
2024
8% Convertible Note of Bioxytran, Inc. to Lender in the Principal Amount of $61,500 dated March 15, 2024
Note Agreements
BIOXYTRAN, INC
2024
Form of Option Agreement dated June 4, 2021
BIOXYTRAN, INC
2023
Form of Closing Agreement with TRITON FUNDS LP, dated September 18, 2023
BIOXYTRAN, INC
2023
Debt Modification Agreement with Note Holder, dated May 5, 2023
Note Agreements
BIOXYTRAN, INC
2023
Amendment to Closing Agreement with TRITON FUNDS LP, dated August 2, 2023
BIOXYTRAN, INC
2023
Form of Closing Agreement with Triton Funds LLC, dated June 8, 2023
BIOXYTRAN, INC
2023
Amendment to engagement letter with WallachBeth Capital LLC, dated May 8, 2023
BIOXYTRAN, INC
2023
Form of Subscription Agreement
Subscription Agreements
BIOXYTRAN, INC
2023
Form of Private Purchase Agreement
Purchase Agreements
BIOXYTRAN, INC
2023
Modification/Amendment to Officers Employment Contract, dated October 28, 2022
Employment Agreements
BIOXYTRAN, INC
2022
Form of Subscription Agreement
Subscription Agreements
BIOXYTRAN, INC
2022
Official USPTO Notice of Publication under 12(A) for the Trademark ProLectin
Trademark Agreements
BIOXYTRAN, INC
Biotechnology
2022
Approval of International Patent WO2022/099061 - Polysaccharides for IV Administration that Treat SARS-CoV-2 Infections, dated May 12, 2022
Administration Agreements
BIOXYTRAN, INC
2022
Approval of International Patent WO2022/099052 - Polysaccharides for Use in Treating Sars-Cov-2 Infections, dated May 12, 2022
BIOXYTRAN, INC
Biotechnology
2022
Form of Note Purchase Agreement, dated January 5, 2022
Note Agreements
BIOXYTRAN, INC
2022
Form of Convertible Note, dated January 5, 2022
Note Agreements
BIOXYTRAN, INC
2022
Form of Private Placement Memorandum dated September 17, 2021
BIOXYTRAN, INC
2021
Form of Private Placement Memorandum dated February 26, 2021
BIOXYTRAN, INC
2021
Form of Subsidiary Option dated June 4, 2021
BIOXYTRAN, INC
2021
Form of Warrant dated June 4, 2021
Warrant Agreements
BIOXYTRAN, INC
Biotechnology
FL
2021
2017 Employee, Director and Consultant Stock Plan (Subsidiary), adopted by the Board of Directors on October 5, 2017
Stock Agreements
BIOXYTRAN, INC
Biotechnology
2021
2021 Employee, Director and Consultant Stock Plan, adopted by the Board of Directors on January 19, 2021
Stock Agreements
BIOXYTRAN, INC
Biotechnology
2021
License Agreement between Pharmalectin, Inc. and NDPD Pharma, Inc. dated May 2, 2021
License Agreements
BIOXYTRAN, INC
2021
License Agreement between Bioxytran, Inc. and Pharmalectin, Inc. dated May 5, 2020
License Agreements
BIOXYTRAN, INC
2021
Form of Convertible Note Agreement between Note Holders and Bioxytran, Inc., dated May 2 and 3, 2021
Note Agreements
BIOXYTRAN, INC
Biotechnology
NV
2021
Form of Employment Agreement of Mike Sheikh, dated May 1, 2020
Employment Agreements
BIOXYTRAN, INC
Biotechnology
CO
2021
Joint Venture Agreement between Bioxytran and Pharmalectin Partners, LLC, dated November 15, 2020
Joint Venture Agreements
BIOXYTRAN, INC
Biotechnology
2021
8% Convertible Debenture of Bioxytran, Inc. to Power Up Lending Group LLC in the Principal Amount of $64,900 dated March 18, 2020
Debenture Agreements
BIOXYTRAN, INC
2020
Securities Purchase Agreement between Power Up Lending Group LLC and Bioxytran, Inc., dated March 18, 2020
Purchase Agreements
BIOXYTRAN, INC
2020
Amendment #1 to Securities Purchase Agreement between Auctus Fund LLC and Bioxytran, Inc., dated February 25, 2019
Purchase Agreements
BIOXYTRAN, INC
2020
Amendment #1 to Securities Purchase Agreement between Auctus Fund LLC and Bioxytran, Inc., dated October 24, 2018
Purchase Agreements
BIOXYTRAN, INC
2020
Securities Purchase Agreement between Crown Bridge Partners, LLC and Bioxytran, Inc., dated October 30, 2019
Purchase Agreements
BIOXYTRAN, INC
Biotechnology
NY
2020
Warrant to Purchase 22,000 shares of Common Stock of Bioxytran
Warrant Agreements
BIOXYTRAN, INC
2020
4% Convertible Note of Bioxytran, Inc. to Crown Bridge Partners, LLC in the Principal Amount of $55,000 dated October 30, 2019
Note Agreements
BIOXYTRAN, INC
Biotechnology
NY
2020
8% Convertible Debenture of Bioxytran, Inc. to Power Up Lending Group LLC in the Principal Amount of $56,600 dated January 18, 2020
Debenture Agreements
BIOXYTRAN, INC
2020
Securities Purchase Agreement between Power Up Lending Group LLC and Bioxytran, Inc., dated January 18, 2020
Purchase Agreements
BIOXYTRAN, INC
2020
Securities Purchase Agreement between EMA Financial LLC and Bioxytran, Inc., dated January 10, 2020
Purchase Agreements
BIOXYTRAN, INC
Biotechnology
NY
2020
4% Convertible Note of Bioxytran, Inc. to EMA Financial LLC. in the Principal Amount of $125,000 dated January 10, 2020
Note Agreements
BIOXYTRAN, INC
2020
Warrant to Purchase 50,000 shares of Common Stock of Bioxytran
Warrant Agreements
BIOXYTRAN, INC
Biotechnology
NY
2020
8% Convertible Note of Bioxytran, Inc. to Power Up Lending Group in the Principal Amount of $54,600 dated December 30, 2019
Note Agreements
BIOXYTRAN, INC
Biotechnology
NY
2020
Securities Purchase Agreement between Power Up Lending Group and Bioxytran, Inc., dated December 30, 2019
Purchase Agreements
BIOXYTRAN, INC
2020
Warrant to Purchase 50,000 shares of Common Stock of Bioxytran
Warrant Agreements
BIOXYTRAN, INC
Biotechnology
2019
4% Convertible Note of Bioxytran, Inc. to FirstFire Global Opportunities Fund, LLC. in the Principal Amount of $125,000 dated November 20, 2019
Note Agreements
BIOXYTRAN, INC
Biotechnology
NY
2019
Securities Purchase Agreement between FirstFire Global Opportunities Fund, LLC and Bioxytran, Inc., dated November 20, 2019
Purchase Agreements
BIOXYTRAN, INC
2019
Form of Letter Agreement between FON Consulting, LLC and Bioxytran, Inc. dated November 11, 2019
Consulting Agreements
BIOXYTRAN, INC
2019
Form of Securities Purchase Agreement between GS Capital Partners, LLC and Bioxytran, Inc., dated No ember 7, 2019
Purchase Agreements
BIOXYTRAN, INC
2019
Form of 4% Convertible Note of Bioxytran, Inc. to GS Capital Partners, LLC. in the Principal Amount of $125,000 dated November 7, 2019
Note Agreements
BIOXYTRAN, INC
Biotechnology
NY
2019
Form of Warrant to Purchase 50,000 shares of Common Stock of Bioxytran
Warrant Agreements
BIOXYTRAN, INC
2019
Securities Purchase Agreement between Peak One Opportunity Fund, L.P. and Bioxytran, Inc., dated October 22, 2019
Purchase Agreements
BIOXYTRAN, INC
Biotechnology
NV
2019
Convertible Debenture of Bioxytran, Inc. to Peak One Opportunity Fund, L.P. in the Principal Amount of $120,000 dated October 22, 2019
Debenture Agreements
BIOXYTRAN, INC
2019
Warrant to Purchase 50,000 shares of Common Stock of Bioxytran
Warrant Agreements
BIOXYTRAN, INC
2019
8% Convertible Note of Bioxytran, Inc. to Tangiers Global, LLC in the Principal Amount of $106,300 dated October 23, 2019
Note Agreements
BIOXYTRAN, INC
Biotechnology
2019
Warrant to Purchase 50,000 shares of Common Stock of Bioxytran
Warrant Agreements
BIOXYTRAN, INC
2019
Securities Purchase Agreement between PowerUp Lending Group Ltd. and Bioxytran, Inc., dated October 21, 2019
Purchase Agreements
BIOXYTRAN, INC
2019
8% Convertible Note of Bioxytran, Inc. to PowerUp Lending Group Ltd. in the Principal Amount of $106,000 dated October 21, 2019
Note Agreements
BIOXYTRAN, INC
Biotechnology
NY
2019
Securities Purchase Agreement between Peak One Opportunity Fund, L.P. and Bioxytran, Inc., dated October 22, 2019
Purchase Agreements
BIOXYTRAN, INC
2019
8% Convertible Debenture of Bioxytran, Inc. to Peak One Opportunity Fund, L.P. in the Principal Amount of $120,000 dated October 22, 2019
Debenture Agreements
BIOXYTRAN, INC
2019
Warrant to Purchase 50,000 shares of Common Stock of Bioxytran
Warrant Agreements
BIOXYTRAN, INC
2019
8% Convertible Note of Bioxytran, Inc. to Tangiers Global, LLC in the Principal Amount of $106,300 dated October 23, 2019
Note Agreements
BIOXYTRAN, INC
Biotechnology
2019
Warrant to Purchase 50,000 shares of Common Stock of Bioxytran
Warrant Agreements
BIOXYTRAN, INC
2019
Securities Purchase Agreement between PowerUp Lending Group Ltd. and Bioxytran, Inc., dated October 21, 2019
Purchase Agreements
BIOXYTRAN, INC
2019
8% Convertible Note of Bioxytran, Inc. to PowerUp Lending Group Ltd. in the Principal Amount of $106,000 dated October 21, 2019
Note Agreements
BIOXYTRAN, INC
Biotechnology
NY
2019
Form of Advisory Board Agreement between Bioxytran, Inc. and Jonathan Jensen Dated September 13, 2019
Advisory Agreements
BIOXYTRAN, INC
Biotechnology
MA
2019
Form of Advisory Board Agreement between Bioxytran, Inc. and Patrick Huddie dated September 13, 2019
Advisory Agreements
BIOXYTRAN, INC
2019
Form of Advisory Board Agreement between Bioxytran, Inc. and Cynthia Tsai effective July 16, 2019
Advisory Agreements
BIOXYTRAN, INC
2019
Form of Advisory Board Agreement between Bioxytran, Inc. and Jonathan Barkman effective July 15, 2019
Advisory Agreements
BIOXYTRAN, INC
2019
Form of Advisory Board Agreement between Bioxytran, Inc. and Steven Aust dated June 11, 2019
Advisory Agreements
BIOXYTRAN, INC
2019
Scientific Advisory Board Agreement between Bioxytran, Inc. and Asclepius LLC dated May 1, 2019
Advisory Agreements
BIOXYTRAN, INC
2019
Investor Relations Agreement between Bioxytran, Inc. and Resources Unlimited NW LLC. dated April 22, 2019
BIOXYTRAN, INC
2019
License Agreement between Bioxytran, Inc. and MDX Lifesciences, Inc. dated April 4, 2019
License Agreements
BIOXYTRAN, INC
Biotechnology
MA
2019
Form of Security Agreement dated February 25, 2019, between U.S. Rare Earth Minerals, Inc., and Auctus Fund, LLC, dated February 25, 2019
Security Agreements
BIOXYTRAN, INC
2019
Form of Warrant of dated February 25, 2019
Warrant Agreements
BIOXYTRAN, INC
2019
Form of Registration Rights Agreement between U.S. Rare Earth Minerals, Inc. and Auctus Fund, LLC, dated February 25, 2019
Registration Rights Agreements
BIOXYTRAN, INC
2019
Form of Securities Purchase Agreement between U.S. Rare Earth Minerals, Inc. and Auctus Fund, LLC, dated February 25, 2019
Purchase Agreements
BIOXYTRAN, INC
2019
Form of $250,000 Senior Secured Promissory Note, dated February 25, 2019, of U.S. Rare Earth Minerals, Inc. and Auctus Fund, LLC, dated February 25, 2019
Note Agreements
BIOXYTRAN, INC
Biotechnology
MA
2019
Form of Employment Agreement of David Platt
Employment Agreements
BIOXYTRAN, INC
Biotechnology
MA
2019
Form of Common Stock Certificate
Stock Agreements
BIOXYTRAN, INC
2019
Form of Employment Agreement of Ola Soderquist
Employment Agreements
BIOXYTRAN, INC
Biotechnology
MA
2019
Form of Public Offering Subscription Agreement
Subscription Agreements
BIOXYTRAN, INC
2019
Form of Employment Agreement of Ola Soderquist
Employment Agreements
BIOXYTRAN, INC
2019
Form of Employment Agreement of David Platt
Employment Agreements
BIOXYTRAN, INC
Biotechnology
MA
2019
Form of Common Stock Certificate
Stock Agreements
BIOXYTRAN, INC
Biotechnology
2019
Form of Securities Purchase Agreement between U.S. Rare Earth Minerals, Inc. and Acutus Fund, LLC, dated October 24, 2018
Purchase Agreements
BIOXYTRAN, INC
2018
Form of Registration Rights Agreement between U.S. Rare Earth Minerals, Inc. and Acutus Fund, LLC, dated October 24, 2018
Registration Rights Agreements
BIOXYTRAN, INC
2018
Form of Warrant of dated October 24, 2018
Warrant Agreements
BIOXYTRAN, INC
Biotechnology
MA
2018
Form of Security Agreement dated October 24, 2018, between U.S. Rare Earth Minerals, Inc., and Acutus Fund, LLC, dated October 24, 2018
Security Agreements
BIOXYTRAN, INC
Biotechnology
MA
2018
Form of $250,000 Senior Secured Promissory Note, dated October 24, 2018, of U.S. Rare Earth Minerals, Inc. and Acutus Fund, LLC, dated October 24, 2018
Note Agreements
BIOXYTRAN, INC
2018
Certificates of Merger merging Bioxy Acquisition Corp. into BioxyTran, Inc. filed with the Secretaries of State of Wyoming and Delaware, effective September 21, 2018
Merger Agreements
BIOXYTRAN, INC
2018
Form of Agreement of Accord and Satisfaction between U.S. Rare Earth Minerals, Inc., and creditor, dated September 17, 2018
BIOXYTRAN, INC
2018
Form of Asset Purchase Agreement between U.S. Rare Earth Minerals, Inc., a Nevada corporation, and U.S. Rare Earth Minerals, Inc. a Wyoming corporation, dated September 17, 2018
Purchase Agreements
BIOXYTRAN, INC
2018
Form of Agreement and Plan of Merger and Reorganization by and among U.S. Rare Earth Minerals, Inc., Bioxy Acquisition Corp and BioxyTran, Inc., dated September 17, 2018
Merger Agreements
BIOXYTRAN, INC
Biotechnology
DE
2018
Stock Exchange Agreement
Exchange Agreements
BIOXYTRAN, INC
2009